2020
DOI: 10.1016/j.annonc.2020.04.205
|View full text |Cite
|
Sign up to set email alerts
|

P-123 Outcomes and predictive factors of regorafenib benefit in patients with metastatic colorectal cancer in a real-life setting

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles